KI
Kisunla
Donanemab, sold under the brand name Kisunla, is a monoclonal antibody used for the treatment of Alzheimer's disease. Donanemab was developed by Eli Lilly and Company.
1Mentions1Articles1Stories0Events0.02Salience
30-day activity pulse
Recent
1
Baseline
0
Ratio
new
Peak
1
Peak article volume on 2026-05-06.
Event Timeline
No linked events available for this entity yet.